−119
CytomX Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−111
FY23:
−56.0
FY24:
−86.2
FY25:
−75.6
Change from FY21 to FY25
millions USD
FY21:
22.5
FY22:
98.3
FY23:
−151
FY24:
99.7
FY25:
−59.7
Change from FY21 to FY25
millions USD
FY21:
110
FY22:
0.65
FY23:
30.2
FY24:
7.52
FY25:
110
(positive)
Change from FY21 to FY25
millions USD
FY21:
−121
FY22:
−113
FY23:
−56.9
FY24:
−86.5
FY25:
−75.8
All amounts in millions USD